TrialEuropean journal of neurology2026

Evaluation of Sustained Disease Control With Nipocalimab Versus Placebo in the Phase 3 Vivacity-MG3 Study.

Tuan Vu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.